Music Therapy for Rehabilitation in Post-stroke Non-fluent Aphasia: the Indian Adaptation
Launched by ALL INDIA INSTITUTE OF MEDICAL SCIENCES · Mar 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach called Melodic Intonation Therapy (MIT) to help people who have had a stroke and struggle with speaking, known as non-fluent aphasia. The researchers want to see how well this Indian version of MIT works compared to standard speech therapy. Participants will receive one of these two treatments and will be monitored for 12 weeks to see how much they improve in their ability to speak.
To join the study, participants need to be at least 18 years old and have had a stroke within the past year that has led to non-fluent aphasia. They should be alert and able to understand simple instructions, and a supportive caregiver is also required. Unfortunately, individuals who have had multiple strokes or certain other health issues may not qualify. Those who participate can expect to receive either the new therapy or standard treatment and will contribute to important research that could help improve recovery for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All of the following
- • 1. Age ≥18 years of age
- • 2. Stroke with non-fluent aphasia, within one year of ictus
- • 3. Imaging evidence suggestive of ischemic or hemorrhagic stroke of dominant hemisphere
- • 4. Patient is alert and able to follow simple commands (should not have global aphasia)
- • 5. Motivated caregiver
- • 6. Informed and signed consent
- Exclusion Criteria:
- Any of the following:
- • 1. Patients with a history of a previous stroke other than the index event, which can explain the aphasia.
- • 2. Any clinical condition (e.g., short life expectancy, coexisting disease) or other characteristics that preclude appropriate follow-up in the study (e.g., distant residence, no family support)
- • 3. Patients participating in any therapeutic intervention clinical trials evaluating poststroke recovery
- • 4. Use of psychotropic drugs that interfere with patient evaluation
About All India Institute Of Medical Sciences
The All India Institute of Medical Sciences (AIIMS) is a premier medical institution and research center in India, recognized for its commitment to advancing healthcare through innovative research and clinical trials. Established with the mission to provide high-quality medical education, patient care, and groundbreaking research, AIIMS plays a pivotal role in the development and evaluation of new therapies and interventions. Its multidisciplinary approach, combined with a robust infrastructure and a team of leading healthcare professionals, positions AIIMS as a key player in the global clinical research landscape, dedicated to improving health outcomes and fostering scientific excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Delhi, Delhi, India
New Delhi, Delhi, India
Delhi, , India
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported